A global view of hepatocellular carcinoma: trends, risk, prevention and management
Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death
worldwide. Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol …
worldwide. Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol …
[HTML][HTML] Predictors of early and late hepatocellular carcinoma recurrence
R Nevola, R Ruocco, L Criscuolo, A Villani… - World journal of …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most frequent liver neoplasm, and its incidence rates
are constantly increasing. Despite the availability of potentially curative treatments (liver …
are constantly increasing. Despite the availability of potentially curative treatments (liver …
Breakthroughs in hepatocellular carcinoma therapies
Several breakthroughs in hepatocellular carcinoma (HCC) therapy across tumor stages
provide hope to improve its dismal prognosis. Although surgical and local ablative therapies …
provide hope to improve its dismal prognosis. Although surgical and local ablative therapies …
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
Background & Aims The effectiveness of direct-acting antivirals (DAAs) against hepatitis C
virus (HCV), following successful treatment of early hepatocellular carcinoma (HCC), has …
virus (HCV), following successful treatment of early hepatocellular carcinoma (HCC), has …
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis
Objective The benefit of direct-acting antivirals (DAAs) against HCV following successful
treatment of hepatocellular carcinoma (HCC) remains controversial. This meta-analysis of …
treatment of hepatocellular carcinoma (HCC) remains controversial. This meta-analysis of …
Direct-acting antiviral therapy for hepatitis C virus infection is associated with increased survival in patients with a history of hepatocellular carcinoma
Background & Aims There is controversy regarding the benefits of direct-acting antiviral
(DAA) therapy for hepatitis C virus (HCV) infection for patients with a history of …
(DAA) therapy for hepatitis C virus (HCV) infection for patients with a history of …
[HTML][HTML] Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common liver malignancy worldwide and a
major cause of cancer-related mortality for which liver resection is an important curative …
major cause of cancer-related mortality for which liver resection is an important curative …
Diagnosis and treatment of VOD/SOS after allogeneic hematopoietic stem cell transplantation
F Bonifazi, F Barbato, F Ravaioli, M Sessa… - Frontiers in …, 2020 - frontiersin.org
Hepatic veno-occlusive disease (VOD) or sinusoidal obstruction syndrome (SOS) is a rare
complication characterized by hepatomegaly, right-upper quadrant pain, jaundice, and …
complication characterized by hepatomegaly, right-upper quadrant pain, jaundice, and …
Incidence of liver-and non-liver-related outcomes in patients with HCV-cirrhosis after SVR
R D'Ambrosio, E Degasperi, MP Anolli, I Fanetti… - Journal of …, 2022 - Elsevier
Background & Aims As the long-term benefits of a sustained virological response (SVR) in
HCV-related cirrhosis following direct-acting antiviral (DAA) treatment remain undefined, we …
HCV-related cirrhosis following direct-acting antiviral (DAA) treatment remain undefined, we …
[HTML][HTML] Viral hepatitis: Milestones, unresolved issues, and future goals
In this review the current overall knowledge on hepatitis A, B, C, D, and E will be discussed.
These diseases are all characterized by liver inflammation but have significant differences in …
These diseases are all characterized by liver inflammation but have significant differences in …